PHARMING GROUP NV's ticker is PHAR and the CUSIP is 71716E105. A total of 4 filers reported holding PHARMING GROUP NV in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $261,659 | +104563.6% | 22,460 | 0.0% | 0.09% | -10.0% |
| Q1 2023 | $250 | +5.0% | 22,460 | +3.9% | 0.10% | +2.0% |
| Q4 2022 | $238 | -99.9% | 21,610 | +29.4% | 0.10% | +4.3% |
| Q3 2022 | $164,000 | +13.1% | 16,700 | +1.2% | 0.09% | +13.3% |
| Q2 2022 | $145,000 | +2.1% | 16,500 | +4.1% | 0.08% | +38.3% |
| Q1 2022 | $142,000 | +7.6% | 15,850 | +7.1% | 0.06% | +33.3% |
| Q4 2021 | $132,000 | +120.0% | 14,800 | +134.9% | 0.04% | +104.5% |
| Q3 2021 | $60,000 | -15.5% | 6,300 | 0.0% | 0.02% | -15.4% |
| Q2 2021 | $71,000 | -51.0% | 6,300 | -61.8% | 0.03% | -68.7% |
| Q2 2020 | $145,000 | – | 16,500 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 169,225 | $1,907,000 | 0.45% |
| Cowen Prime Advisors LLC | 6,300 | $71,000 | 0.03% |
| Cowen Prime Services LLC | 6,300 | $71,000 | 0.03% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 2,548 | $29,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 89 | $1,000 | 0.00% |
| JANE STREET GROUP, LLC | 12,674 | $144,000 | 0.00% |
| UBS Group AG | 1,319 | $15,000 | 0.00% |